Directory
Elias Jatem Escalante

Elias Jatem Escalante

Degree: Graduate


Publications

  • Gonzalez J; Jatem E; Roig J; Valtierra N; Ostos E; Abo A; Santacana M; Garcia A; Segarra A

    Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.

    NEPHROLOGY DIALYSIS TRANSPLANTATION 37 2102-2110. .

    [doi:10.1093/ndt/gfac185]

  • Roca, Neus; Jatem, Elias; Abo, Anabel; Santacana, Maria; Cruz, Alejandro; Madrid, Alvaro; Fraga, Gloria; Martin, Marisa; Gonzalez, Jorge; Martinez, Cristina; Balius, Anna; Segarra, Alfons

    CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome.

    CLINICAL KIDNEY JOURNAL 15 545-552. .

    [doi:10.1093/ckj/sfab215]

  • Medrano AS; Muijsemberg A; Wimbury D; Martin M; Jatem E; González J; Colás-Campás L; García-Carrasco A; Martínez C; Barratt J

    Relationship between IgA1 lectin-binding specificities, mesangial C4d deposits and clinical phenotypes in IgA nephropathy.

    NEPHROLOGY DIALYSIS TRANSPLANTATION 37 318-325. .

    [doi:10.1093/ndt/gfaa356]

  • Molina, Maria; Sorolla, Carolina; Samso, Elisabet; Carcaña M; Martín ML; Jatem, Elias; Pitarch, Griselda; Montero, Laura; Lauzurica, Ricardo; Segarra, Alfons

    Cost of Traveling to Follow-up Appointments at Kidney Transplant Clinics.

    TRANSPLANTATION PROCEEDINGS 54 94-95. .

    [doi:10.1016/j.transproceed.2021.11.005]

  • Molina, Maria; Sorolla, Carolina; Samso, Elisabet; Carcaña M; Martín ML; Jatem, Elias; Pitarch, Griselda; Montero, Laura; Lauzurica, Ricardo; Segarra, Alfons

    Quality of Life in Long-Term Renal Transplant Patients: A Controversial Subject.

    TRANSPLANTATION PROCEEDINGS 54 91-93. .

    [doi:10.1016/j.transproceed.2021.11.025]

  • Jatem-Escalante, E; Martin-Conde, ML; Gracia-Lavedan, E; Benitez, ID; Gonzalez, J; Colas, L; Garcia-Carrasco, A; Martinez, C; Segarra-Medrano, A

    Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy

    CLINICAL KIDNEY JOURNAL 14 2556-2562. .

    [doi:10.1093/ckj/sfab116]

  • Del Carpio, J; Marco, MP; Martin, ML; Craver, L; Jatem, E; Gonzalez, J; Chang, P; Ibarz, M; Pico, S; Falcon, G; Canales, M; Huertas, E; Romero, I; Nieto, N; Segarra, A

    External validation of the Madrid Acute Kidney Injury Prediction Score

    CLINICAL KIDNEY JOURNAL 14 2377-2382. .

    [doi:10.1093/ckj/sfab068]

  • Roca N; Madrid A; Lopez M; Fraga G; Jatem E; Gonzalez J; Martinez C; Segarra A

    Multidimensional inflammatory and immunological endotypes of idiopathic focal segmental glomerulosclerosis and their association with treatment outcomes.

    CLINICAL KIDNEY JOURNAL 14 1826-1834. .

    [doi:10.1093/ckj/sfaa265]

  • Roca N; Martinez C; Jatem E; Madrid A; Lopez M; Segarra A

    Activation of the acute inflammatory phase response in idiopathic nephrotic syndrome: association with clinicopathological phenotypes and with response to corticosteroids.

    CLINICAL KIDNEY JOURNAL 14 1207-1215. .

    [doi:10.1093/ckj/sfaa247]

  • Roca N; Jatem E; Martín ML; Muñoz M; Molina M; Martínez C; Segarra A

    Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome.

    CLINICAL KIDNEY JOURNAL 14 543-549. .

    [doi:10.1093/ckj/sfz173]

  • Jatem, E; Lima, J; Montoro, B; Torres-Bondia, F; Segarra, A

    Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome

    Kidney International Reports 6 101-109. .

    [doi:10.1016/j.ekir.2020.09.046]

  • Segarra, A; Arredondo, KV; Jaramillo, J; Jatem, E; Salcedo, MT; Agraz, I; Ramos, N; Carnicer, C; Valtierra, N; Ostos, E

    Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience.

    Lupus 29 118-125. .

    [doi:10.1177/0961203319896018]